Literature DB >> 20609859

Delayed cutaneous manifestations of drug hypersensitivity.

Andreas J Bircher1, Kathrin Scherer.   

Abstract

Drugs may elicit a considerable variety of clinical signs, often affecting the skin and the mucous membranes. The most common are maculopapular exanthemas and urticaria, more rarely pustules, bullae vasculitic lesions, and lichenoid lesions may also be observed. Apart from the morphology, the chronology of the occurrence and the evolution of single skin lesions and exanthema are also paramount in the clinical diagnosis of cutaneous drug hypersensitivity. Often, the skin represents the only organ manifestation; however, it may be the herald for a systemic involvement of internal organs, such as in severe drug-induced hypersensitivity syndromes or anaphylaxis. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20609859     DOI: 10.1016/j.mcna.2010.04.001

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  14 in total

1.  Lichenoid drug reaction to antituberculosis drugs treated through with topical steroids and phototherapy.

Authors:  Rannakoe J Lehloenya; Gail Todd; Lesiba Mogotlane; Nomphelo Gantsho; Carol Hlela; Keertan Dheda
Journal:  J Antimicrob Chemother       Date:  2012-06-11       Impact factor: 5.790

Review 2.  [Lichenoid drug reactions].

Authors:  H F Merk; L Vanstreels; M Megahed
Journal:  Hautarzt       Date:  2018-02       Impact factor: 0.751

3.  A Critical Evaluation of Safety Signal Analysis Using Algorithmic Standardised MedDRA Queries.

Authors:  Carolyn Tieu; Christopher D Breder
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

4.  Pancrelipase-Induced Hypersensitivity Reaction: Case Report and Review of Literature.

Authors:  Jason A Adler; Muhammad W Saif
Journal:  JOP       Date:  2018-09

Review 5.  Eosinophilic Drug Allergy.

Authors:  Merin Kuruvilla; David A Khan
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

6.  Categorization of allergic disorders in the new World Health Organization International Classification of Diseases.

Authors:  Luciana Kase Tanno; Moises A Calderon; Bruce J Goldberg; Cezmi A Akdis; Nikolaos G Papadopoulos; Pascal Demoly
Journal:  Clin Transl Allergy       Date:  2014-11-28       Impact factor: 5.871

Review 7.  Dissemination of definitions and concepts of allergic and hypersensitivity conditions.

Authors:  Luciana Kase Tanno; Moises A Calderon; Helen E Smith; Mario Sanchez-Borges; Aziz Sheikh; Pascal Demoly
Journal:  World Allergy Organ J       Date:  2016-08-09       Impact factor: 4.084

Review 8.  Adverse cutaneous drug eruptions: current understanding.

Authors:  W Hoetzenecker; M Nägeli; E T Mehra; A N Jensen; I Saulite; P Schmid-Grendelmeier; E Guenova; A Cozzio; L E French
Journal:  Semin Immunopathol       Date:  2015-11-09       Impact factor: 11.759

Review 9.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

10.  Warfarin-induced leukocytoclastic vasculitis and proteinuria.

Authors:  Khalid Jumean; Ahmad Abu Arqoub; Amer Hawatmeh; Firas Qaqa; Ayham Bataineh; Hamid Shaaban
Journal:  J Family Med Prim Care       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.